Physical Exercise for Augmenting Cognitive Health (PEACH) (PEACH)

February 5, 2024 updated by: Kirk Erickson, PhD, University of Pittsburgh

Physical Exercise for Augmenting Cognitive Health

PEACH is a pilot project which is being conducted to determine the feasibility and acceptability of a 12-week home-based exercise intervention among Black and African American adults. A secondary aim of the project is to determine whether the exercise intervention improves cognitive and psychological functioning.

Study Overview

Detailed Description

This pilot project aims to address the impact of early life adversity (ELA) on brain health in adulthood by conducting a pilot 12-week physical activity (PA) intervention delivered remotely using aerobic exercise bikes programmed to connect users with a trainer via an app. Investigators will recruit Black and African American individuals between the ages of 30-55 years (N = 40) who are currently sedentary and report experiencing at least one form of ELA prior to the age of 10. This study will be conducted at two sites: the University of Pittsburgh in Pittsburgh, PA, USA and the University of the West Indies in Kingston, Jamaica (site investigator: Terrence Forrester). At baseline and following the 12-week intervention, Investigators will collect a harmonized battery of cognitive, behavioral and psychosocial measures. The intervention itself will be home-based and will involve three 60-minute sessions of aerobic exercise per week using a Bluetooth-enable exercise bike. Participants' exercise programs will be supervised remotely by an exercise trainer and individualized depending on their age-adjusted heart rate reserve, with the goal being to have participants reach 50 minutes of moderate to vigorous intensity exercise per session by the end of the first 4 weeks of the intervention. The bikes will be outfitted with a tablet featuring an application called Neotiv. The Neotiv application will collect data from the bike regarding timing, duration, and intensity of exercise sessions, which will be securely shared with the exercise trainer to monitor attendance and adherence. The primary goals of this study are to determine whether the home-based exercise program (1) is feasible and acceptable (as measured by adherence and attendance), and (2) promotes improvements in cognitive and psychological functioning among adults who have been exposed to ELA.

Study Type

Interventional

Enrollment (Actual)

4

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Kingston, Jamaica
        • University of the West Indies
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15220-2505
        • Sennott Square

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. adults aged 30-55 years
  2. exposure to at least one form of threat-related adversity (e.g., exposure to violence; physical abuse) occurring prior to age 10 as documented by retrospective self-report
  3. Self-identified Black or African American Race
  4. access to high-speed internet
  5. sedentary lifestyle (<60 minutes of PA/week).
  6. no difficulties with mobility
  7. Does not currently require the use of an assisted walking device
  8. Does not have a history of balance difficulties
  9. Not currently pregnant or planning to become pregnant in the next 12 months

Exclusion Criteria:

  1. Psychosis
  2. Significant suicide risk (i.e., current, active suicidal ideation with a plan)
  3. Engaging in moderate-intensity exercise >=20 min per day, >=3 times per week
  4. Current treatment for cancer
  5. Neurological condition (MS, Parkinson's, Dementia, MCI) or brain injury (Stroke)
  6. Substance use disorder in the past 3-months
  7. Current treatment for congestive heart failure, angina, uncontrolled arrhythmia, deep vein thrombosis (DVT) or other cardiovascular event
  8. Myocardial infarction, coronary artery bypass grafting, angioplasty or other cardiac condition in the past year
  9. Sensory Impairment that would preclude neuropsychological testing
  10. Not fluent in English
  11. Travelling consecutively for 2+ weeks during the study
  12. uncontrolled hypertension
  13. Insulin-Dependent Diabetes Mellitus
  14. Self-identified race anything other than Black or African American
  15. Currently pregnant or planning to become pregnant in the next 12 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Home-based aerobic exercise
Un-supervised exercise will be held 3 times a week for 60 minutes in the participant's home
Guidelines for exercise programming (ACSM, 2018) will be followed including a warmup and cool down, progressive and gradual increments in duration, and instruction regarding avoidance of physical activity related injury. The exercise group will receive moderate to vigorous intensity aerobic exercise for 60 minutes per day, three times a week, for 12 weeks. The prescribed intensity will be based on estimated heart rate reserve, calculated using resting heart rate and age-adjusted heart rate maximum (220-age in years). Participants will maintain a minimum heart rate from their specific calculation that will be monitored by Polar Heart Rate straps.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to exercise intervention program: Number of sessions completed
Time Frame: baseline to 12 weeks
Data regarding the number of exercise sessions completed will be collected to operationalize adherence. Adherence will be used as a metric of feasibility and acceptability.
baseline to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to exercise intervention program: Average minutes spent in moderate to vigorous exercise
Time Frame: baseline to 12 weeks
Data regarding the average number of minutes spent engaging in moderate to vigorous exercise (via heart rate monitoring and comparison of heart rate to calculations based on heart rate reserve) will be collected to operationalize adherence. Adherence will be used as a metric of feasibility and acceptability.
baseline to 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to exercise intervention program: Average duration of sessions
Time Frame: baseline to 12 weeks
Data regarding the average duration of sessions will be collected to operationalize adherence. Adherence will be used as a metric of feasibility and acceptability.
baseline to 12 weeks
Mean change in negative and positive affect
Time Frame: baseline to 12 weeks
This will be calculated via scores from the Positive and Negative Affect Scale. Scores can range from 1 to 100, with 1 meaning less positive affect and 100 meaning more positive affect.
baseline to 12 weeks
Mean change in depressive symptoms
Time Frame: baseline to 12 weeks
Participants will complete the Center for Epidemiological Studies-Depression Scale, a measure of the frequency of 20 common depressive symptoms rated along a 0 ("rarely or none of the time") to 3 ("most or all of the time") Likert scale. Responses are summed to yield a total symptom score (maximum possible score of 60) with higher scores reflecting more severe depressive symptoms.
baseline to 12 weeks
Mean change in perceived stress
Time Frame: baseline to 12 weeks
Participants will complete the Perceived Stress Scale (PSS) a measure of the frequency of 20 common depressive symptoms rated along a 0 ("rarely or non, a 14-item measure that assesses experiences of daily life stress. The PSS is an instrument on which respondents use a 0 ("never") to 4 ("very often") Likert scale to rate the degree to which daily life events are perceived to be uncontrollable, unpredictable, or unmanageable. Responses are summed to form a total score (maximum possible score of 56).
baseline to 12 weeks
Mean change in Flanker performance
Time Frame: baseline to 12 weeks
A Flanker task will be administered at baseline, and then following the intervention (12-weeks). The main outcome from this task is an interference effect (in ms) which indicates how much longer it takes for a participant to make a directional response to a center arrow when the flanking arrows are arranged in congruent vs. incongruent direction from the center stimulus. A higher interference effect indicates worse executive functioning.
baseline to 12 weeks
Mean change in Picture Sequence performance
Time Frame: baseline to 12 weeks
A Picture Sequence task will be administered at baseline, and then following the intervention (12-weeks). The main outcome from this task is the cumulative number of adjacent pictures in which a participant correctly remembered the sequence. A lower number of correct items indicates worse episodic memory.
baseline to 12 weeks
Mean change in Dimensional Card Sort performance
Time Frame: baseline to 12 weeks
A Dimensional Card Sort task will be administered at baseline, and then following the intervention (12-weeks). The main outcome from this task is an interference effect (in ms) which indicates how much longer it takes for a participant to match a stimulus to other choice stimuli based on a feature (shape or color), with the feature participants must match on switching without warning during the task. A higher interference effect indicates worse executive functioning.
baseline to 12 weeks
Mean change in List Sorting performance
Time Frame: baseline to 12 weeks
A List Sorting task will be administered at baseline, and then following the intervention (12-weeks). Participants will be presented with a series of stimuli and then be asked to repeat the stimuli in order of size from smallest to largest. The main outcome from this task is total items answered correctly, with a lower scoring being indicative or worse working memory.
baseline to 12 weeks
Mean change in Pattern Comparison performance
Time Frame: baseline to 12 weeks
A Pattern Comparison task will be administered at baseline, and then following the intervention (12-weeks). Participants will be presented with visual patterns and asked to respond whether the patterns are the same or different. The main outcome from this task is total items answered correctly in the 90 seconds allotted for the task, with a lower number of items being indicative or worse processing speed.
baseline to 12 weeks
Mean change in Picture Vocabulary performance
Time Frame: baseline to 12 weeks
A Picture Vocabulary task will be administered at baseline, and then following the intervention (12-weeks). Participants will be presented with visual stimuli along with an auditory cue and will have to judge which of the visual stimuli match the auditory cue. The main outcome from this task is total items answered correctly, with a lower number of items being indicative or worse language ability.
baseline to 12 weeks
Mean change in systolic blood pressure
Time Frame: baseline to 12 weeks
Systolic blood pressure (SBP) will be measured at baseline and 12-weeks to determine whether there is a change in SBP.
baseline to 12 weeks
Mean change in physical activity
Time Frame: baseline to 12 weeks
Participants will complete one week of actigraphy at baseline and again at follow-up to determine whether physical activity levels change. This will be operationalized as change in average number of steps per day.
baseline to 12 weeks
Mean change in heart rate
Time Frame: baseline to 12 weeks
Heart rate will be measured throughout the intervention and changes in heart rate from baseline to the end of the intervention will be calculated.
baseline to 12 weeks
Percent change in total body weight
Time Frame: baseline to 12 weeks
Participants will be weighed on a calibrated stadiometer both before and after the intervention. The investigators will examine percent changes in body weight before and after the intervention.
baseline to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kirk I Erickson, PhD, University of Pittsburgh

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 4, 2022

Primary Completion (Actual)

May 3, 2023

Study Completion (Actual)

May 30, 2023

Study Registration Dates

First Submitted

June 8, 2021

First Submitted That Met QC Criteria

June 8, 2021

First Posted (Actual)

June 11, 2021

Study Record Updates

Last Update Posted (Actual)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 5, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY20120192
  • R24AG065174-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data from this study will be made available to outside investigators under a data-sharing agreement. The data will be available to outside investigators after publication of the primary aims and at completion of quality control assessments and data organization. The investigators expect that the data from this study will result in interest from internal and external investigators for secondary analysis and ancillary projects.

IPD Sharing Time Frame

Will be made available after study investigators have published summary data and primary aims results. Will be available for unlimited amount of time.

IPD Sharing Access Criteria

Data requests will be approved by the PI and Co-PIs.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Aging

Clinical Trials on Home-based aerobic exercise

3
Subscribe